Resultats de la cerca - Agnes Witkiewicz

  • Mostrar 1 - 5 resultats de 5
Refinar resultats
  1. 1
    RB-pathway disruption in breast cancer

    RB-pathway disruption in breast cancer per Adam Ertel, Jeffry L. Dean, Hallgeir Rui, Chengbao Liu, Agnes Witkiewicz, Karen E. Knudsen, Erik S. Knudsen

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells

    Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells per Christine L. Hostetter, Lauren A. Licata, Christina L. Costantino, Agnes Witkiewicz, Charles Yeo, Jonathan R. Brody, Judith C. Keen

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    The Cell Fate Determination Factor Dachshund Inhibits Androgen Receptor Signaling and Prostate Cancer Cellular Growth

    The Cell Fate Determination Factor Dachshund Inhibits Androgen Receptor Signaling and Prostate Cancer Cellular Growth per Kongming Wu, Sanjay Katiyar, Agnes Witkiewicz, Anping Li, Peter A. McCue, Liang‐Nian Song, Lifeng Tian, Ming Jin, Richard G. Pestell

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil: Is it time to move forward?

    Evaluating the drug-target relationship between thymidylate synthase expression and tumor response to 5-fluorouracil: Is it time to move forward? per Shayna L. Showalter, Timothy N. Showalter, Agnes Witkiewicz, Robert I. Havens, Eugene P. Kennedy, Tomáš Hucl, Scott E. Kern, Charles J. Yeo, Jonathan R. Brody

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer

    Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer per Lyndsay N. Harris, Fanglei You, Stuart J. Schnitt, Agnes Witkiewicz, Xin Lü, Dennis C. Sgroi, Paula D. Ryan, Steven E. Come, Harold J. Burstein, Beth-Ann Lesnikoski, Madhavi Kamma, Paula N. Friedman, Rebecca Gelman, J. Dirk Iglehart, Eric P. Winer

    Publicat 2007
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: